ODE
GILD icon

O'Domhnaill Enterprises’s Gilead Sciences GILD Stock Holding History

O'Domhnaill Enterprises’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Buy
16,585
+1,387
+9% +$183K 1.67% 27
2026
Q1 		$2.12M Buy
+15,198
New +$2.13M 1.71% 24

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

O'Domhnaill Enterprises's GILD Position: Q2 2026 in Review

O'Domhnaill Enterprises increased its Gilead Sciences (GILD) stake by 9.1% in Q2 2026, buying an estimated $183K and bringing the position to 16,585 shares worth $2.1M. The position accounts for 1.67% of the portfolio, ranked #27.

O'Domhnaill Enterprises first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.12M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • O'Domhnaill Enterprises held 16,585 shares of Gilead Sciences worth $2.1M as of Q2 2026.
  • O'Domhnaill Enterprises bought 1,387 Gilead Sciences shares in Q2 2026, an estimated $183K.
  • Gilead Sciences made up 1.67% of O'Domhnaill Enterprises's portfolio in Q2 2026, its #27 holding.
  • O'Domhnaill Enterprises first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • O'Domhnaill Enterprises's Gilead Sciences position peaked at $2.12M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on O'Domhnaill Enterprises's 13F filing for Q2 2026, filed 30 Jul 2026.